Terms ending in 2040
Every in-force patent on BioAtla Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,851,499 | Conditionally Active Anti-Epcam Antibodies, Antibody Fragments, Their Immunoconjugates and Uses Thereof In force · Medium confidence | BioAtla, Inc. | In force | Medium confidence | |
| US 12,427,347 | Conditionally Active Anti-Epcam Antibodies, Antibody Fragments, Their Immunoconjugates and Uses Thereof In force · Low confidence | BioAtla, Inc. | In force | Low confidence |
2 of 2 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.